フュージョントランススクリプトアッセイの世界市場2023年:フュージョントランススクリプトキット、PCR装置

■ 英語タイトル:Global Fusion Transcript Assays Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QYR23MA7906)■ 発行会社/調査会社:QYResearch
■ 商品コード:QYR23MA7906
■ 発行日:2023年3月
■ 調査対象地域:グローバル
■ 産業分野:医療機器
■ ページ数:86
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後2-3営業日)
■ 販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥440,800見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,350 ⇒換算¥661,200見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,800 ⇒換算¥881,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[フュージョントランススクリプトアッセイの世界市場2023年:フュージョントランススクリプトキット、PCR装置]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

当調査資料はフュージョントランススクリプトアッセイのグローバル市場について調査・分析し、世界のフュージョントランススクリプトアッセイ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析(フュージョントランススクリプトキット、PCR装置)、用途別セグメント分析(病院、がん研究施設、診断所、その他)、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Thermo Fisher Scientific、Illumina, Inc.、Merck Millipore、Hologic Inc.、Hologic Inc Bio-Rad Laboratories Inc.、Caris Life Sciences、SeraCare Life Sciences Inc.、QIAGENなどが含まれています。フュージョントランススクリプトアッセイのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX%です。新型コロナとロシア・ウクライナ戦争の影響は、フュージョントランススクリプトアッセイ市場規模を算出する際に考慮しました。

・フュージョントランススクリプトアッセイ市場の概要
- フュージョントランススクリプトアッセイの種類別セグメント
- 世界のフュージョントランススクリプトアッセイ市場規模:タイプ別分析(フュージョントランススクリプトキット、PCR装置)
- フュージョントランススクリプトアッセイの用途別セグメント
- 世界のフュージョントランススクリプトアッセイ市場規模:用途別分析(病院、がん研究施設、診断所、その他)
- 世界のフュージョントランススクリプトアッセイ市場規模予測(2018年-2029年)

・フュージョントランススクリプトアッセイ市場の成長トレンド
- フュージョントランススクリプトアッセイの地域別市場規模(2018年-2029年)
- フュージョントランススクリプトアッセイ市場ダイナミクス
- フュージョントランススクリプトアッセイの業界動向
- フュージョントランススクリプトアッセイ市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M&A動向

・種類別セグメント:フュージョントランススクリプトキット、PCR装置
- 世界のフュージョントランススクリプトアッセイのタイプ別市場規模(2018年-2023年)
- 世界のフュージョントランススクリプトアッセイのタイプ別市場規模(2024年-2029年)

・用途別セグメント:病院、がん研究施設、診断所、その他
- 世界のフュージョントランススクリプトアッセイの用途別市場規模(2018年-2023年)
- 世界のフュージョントランススクリプトアッセイの用途別市場規模(2024年-2029年)

・フュージョントランススクリプトアッセイの地域別市場規模
- 北米のフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- 米国のフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- ヨーロッパのフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- アジア太平洋のフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- 中国のフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- 日本のフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- 韓国のフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- インドのフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- オーストラリアのフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- 中南米のフュージョントランススクリプトアッセイ市場規模(2018年-2029年)
- 中東・アフリカのフュージョントランススクリプトアッセイ市場規模(2018年-2029年)

・主要企業のプロファイル:企業情報、事業概要、売上、動向
Thermo Fisher Scientific、Illumina, Inc.、Merck Millipore、Hologic Inc.、Hologic Inc Bio-Rad Laboratories Inc.、Caris Life Sciences、SeraCare Life Sciences Inc.、QIAGEN

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Fusion Transcript Assays market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Fusion Transcript Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Fusion Transcript Assays is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Fusion Transcript Assays in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Fusion Transcript Assays include Thermo Fisher Scientific, Illumina, Inc., Merck Millipore, Hologic Inc., Hologic Inc Bio-Rad Laboratories Inc., Caris Life Sciences, SeraCare Life Sciences Inc. and QIAGEN, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fusion Transcript Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fusion Transcript Assays.
The Fusion Transcript Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Fusion Transcript Assays market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fusion Transcript Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Illumina, Inc.
Merck Millipore
Hologic Inc.
Hologic Inc Bio-Rad Laboratories Inc.
Caris Life Sciences
SeraCare Life Sciences Inc.
QIAGEN
Segment by Type
Fusion Transcript Kits
PCR Devices
Segment by Application
Hospital
Cancer Research Center
Diagnostic Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fusion Transcript Assays companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fusion Transcript Assays Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Fusion Transcript Kits
1.2.3 PCR Devices
1.3 Market by Application
1.3.1 Global Fusion Transcript Assays Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Cancer Research Center
1.3.4 Diagnostic Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fusion Transcript Assays Market Perspective (2018-2029)
2.2 Fusion Transcript Assays Growth Trends by Region
2.2.1 Global Fusion Transcript Assays Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fusion Transcript Assays Historic Market Size by Region (2018-2023)
2.2.3 Fusion Transcript Assays Forecasted Market Size by Region (2024-2029)
2.3 Fusion Transcript Assays Market Dynamics
2.3.1 Fusion Transcript Assays Industry Trends
2.3.2 Fusion Transcript Assays Market Drivers
2.3.3 Fusion Transcript Assays Market Challenges
2.3.4 Fusion Transcript Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fusion Transcript Assays Players by Revenue
3.1.1 Global Top Fusion Transcript Assays Players by Revenue (2018-2023)
3.1.2 Global Fusion Transcript Assays Revenue Market Share by Players (2018-2023)
3.2 Global Fusion Transcript Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fusion Transcript Assays Revenue
3.4 Global Fusion Transcript Assays Market Concentration Ratio
3.4.1 Global Fusion Transcript Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fusion Transcript Assays Revenue in 2022
3.5 Fusion Transcript Assays Key Players Head office and Area Served
3.6 Key Players Fusion Transcript Assays Product Solution and Service
3.7 Date of Enter into Fusion Transcript Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fusion Transcript Assays Breakdown Data by Type
4.1 Global Fusion Transcript Assays Historic Market Size by Type (2018-2023)
4.2 Global Fusion Transcript Assays Forecasted Market Size by Type (2024-2029)
5 Fusion Transcript Assays Breakdown Data by Application
5.1 Global Fusion Transcript Assays Historic Market Size by Application (2018-2023)
5.2 Global Fusion Transcript Assays Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Fusion Transcript Assays Market Size (2018-2029)
6.2 North America Fusion Transcript Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Fusion Transcript Assays Market Size by Country (2018-2023)
6.4 North America Fusion Transcript Assays Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fusion Transcript Assays Market Size (2018-2029)
7.2 Europe Fusion Transcript Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Fusion Transcript Assays Market Size by Country (2018-2023)
7.4 Europe Fusion Transcript Assays Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fusion Transcript Assays Market Size (2018-2029)
8.2 Asia-Pacific Fusion Transcript Assays Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Fusion Transcript Assays Market Size by Region (2018-2023)
8.4 Asia-Pacific Fusion Transcript Assays Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fusion Transcript Assays Market Size (2018-2029)
9.2 Latin America Fusion Transcript Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Fusion Transcript Assays Market Size by Country (2018-2023)
9.4 Latin America Fusion Transcript Assays Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fusion Transcript Assays Market Size (2018-2029)
10.2 Middle East & Africa Fusion Transcript Assays Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Fusion Transcript Assays Market Size by Country (2018-2023)
10.4 Middle East & Africa Fusion Transcript Assays Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Fusion Transcript Assays Introduction
11.1.4 Thermo Fisher Scientific Revenue in Fusion Transcript Assays Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Illumina, Inc.
11.2.1 Illumina, Inc. Company Detail
11.2.2 Illumina, Inc. Business Overview
11.2.3 Illumina, Inc. Fusion Transcript Assays Introduction
11.2.4 Illumina, Inc. Revenue in Fusion Transcript Assays Business (2018-2023)
11.2.5 Illumina, Inc. Recent Development
11.3 Merck Millipore
11.3.1 Merck Millipore Company Detail
11.3.2 Merck Millipore Business Overview
11.3.3 Merck Millipore Fusion Transcript Assays Introduction
11.3.4 Merck Millipore Revenue in Fusion Transcript Assays Business (2018-2023)
11.3.5 Merck Millipore Recent Development
11.4 Hologic Inc.
11.4.1 Hologic Inc. Company Detail
11.4.2 Hologic Inc. Business Overview
11.4.3 Hologic Inc. Fusion Transcript Assays Introduction
11.4.4 Hologic Inc. Revenue in Fusion Transcript Assays Business (2018-2023)
11.4.5 Hologic Inc. Recent Development
11.5 Hologic Inc Bio-Rad Laboratories Inc.
11.5.1 Hologic Inc Bio-Rad Laboratories Inc. Company Detail
11.5.2 Hologic Inc Bio-Rad Laboratories Inc. Business Overview
11.5.3 Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Introduction
11.5.4 Hologic Inc Bio-Rad Laboratories Inc. Revenue in Fusion Transcript Assays Business (2018-2023)
11.5.5 Hologic Inc Bio-Rad Laboratories Inc. Recent Development
11.6 Caris Life Sciences
11.6.1 Caris Life Sciences Company Detail
11.6.2 Caris Life Sciences Business Overview
11.6.3 Caris Life Sciences Fusion Transcript Assays Introduction
11.6.4 Caris Life Sciences Revenue in Fusion Transcript Assays Business (2018-2023)
11.6.5 Caris Life Sciences Recent Development
11.7 SeraCare Life Sciences Inc.
11.7.1 SeraCare Life Sciences Inc. Company Detail
11.7.2 SeraCare Life Sciences Inc. Business Overview
11.7.3 SeraCare Life Sciences Inc. Fusion Transcript Assays Introduction
11.7.4 SeraCare Life Sciences Inc. Revenue in Fusion Transcript Assays Business (2018-2023)
11.7.5 SeraCare Life Sciences Inc. Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Detail
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Fusion Transcript Assays Introduction
11.8.4 QIAGEN Revenue in Fusion Transcript Assays Business (2018-2023)
11.8.5 QIAGEN Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Fusion Transcript Assays Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Fusion Transcript Kits
Table 3. Key Players of PCR Devices
Table 4. Global Fusion Transcript Assays Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Fusion Transcript Assays Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Fusion Transcript Assays Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Fusion Transcript Assays Market Share by Region (2018-2023)
Table 8. Global Fusion Transcript Assays Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Fusion Transcript Assays Market Share by Region (2024-2029)
Table 10. Fusion Transcript Assays Market Trends
Table 11. Fusion Transcript Assays Market Drivers
Table 12. Fusion Transcript Assays Market Challenges
Table 13. Fusion Transcript Assays Market Restraints
Table 14. Global Fusion Transcript Assays Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Fusion Transcript Assays Market Share by Players (2018-2023)
Table 16. Global Top Fusion Transcript Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Transcript Assays as of 2022)
Table 17. Ranking of Global Top Fusion Transcript Assays Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Fusion Transcript Assays Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fusion Transcript Assays Product Solution and Service
Table 21. Date of Enter into Fusion Transcript Assays Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fusion Transcript Assays Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Fusion Transcript Assays Revenue Market Share by Type (2018-2023)
Table 25. Global Fusion Transcript Assays Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Fusion Transcript Assays Revenue Market Share by Type (2024-2029)
Table 27. Global Fusion Transcript Assays Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Fusion Transcript Assays Revenue Market Share by Application (2018-2023)
Table 29. Global Fusion Transcript Assays Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Fusion Transcript Assays Revenue Market Share by Application (2024-2029)
Table 31. North America Fusion Transcript Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Fusion Transcript Assays Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Fusion Transcript Assays Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Fusion Transcript Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Fusion Transcript Assays Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Fusion Transcript Assays Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Fusion Transcript Assays Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Fusion Transcript Assays Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Fusion Transcript Assays Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Fusion Transcript Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Fusion Transcript Assays Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Fusion Transcript Assays Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Fusion Transcript Assays Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Fusion Transcript Assays Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Fusion Transcript Assays Market Size by Country (2024-2029) & (US$ Million)
Table 46. Thermo Fisher Scientific Company Detail
Table 47. Thermo Fisher Scientific Business Overview
Table 48. Thermo Fisher Scientific Fusion Transcript Assays Product
Table 49. Thermo Fisher Scientific Revenue in Fusion Transcript Assays Business (2018-2023) & (US$ Million)
Table 50. Thermo Fisher Scientific Recent Development
Table 51. Illumina, Inc. Company Detail
Table 52. Illumina, Inc. Business Overview
Table 53. Illumina, Inc. Fusion Transcript Assays Product
Table 54. Illumina, Inc. Revenue in Fusion Transcript Assays Business (2018-2023) & (US$ Million)
Table 55. Illumina, Inc. Recent Development
Table 56. Merck Millipore Company Detail
Table 57. Merck Millipore Business Overview
Table 58. Merck Millipore Fusion Transcript Assays Product
Table 59. Merck Millipore Revenue in Fusion Transcript Assays Business (2018-2023) & (US$ Million)
Table 60. Merck Millipore Recent Development
Table 61. Hologic Inc. Company Detail
Table 62. Hologic Inc. Business Overview
Table 63. Hologic Inc. Fusion Transcript Assays Product
Table 64. Hologic Inc. Revenue in Fusion Transcript Assays Business (2018-2023) & (US$ Million)
Table 65. Hologic Inc. Recent Development
Table 66. Hologic Inc Bio-Rad Laboratories Inc. Company Detail
Table 67. Hologic Inc Bio-Rad Laboratories Inc. Business Overview
Table 68. Hologic Inc Bio-Rad Laboratories Inc. Fusion Transcript Assays Product
Table 69. Hologic Inc Bio-Rad Laboratories Inc. Revenue in Fusion Transcript Assays Business (2018-2023) & (US$ Million)
Table 70. Hologic Inc Bio-Rad Laboratories Inc. Recent Development
Table 71. Caris Life Sciences Company Detail
Table 72. Caris Life Sciences Business Overview
Table 73. Caris Life Sciences Fusion Transcript Assays Product
Table 74. Caris Life Sciences Revenue in Fusion Transcript Assays Business (2018-2023) & (US$ Million)
Table 75. Caris Life Sciences Recent Development
Table 76. SeraCare Life Sciences Inc. Company Detail
Table 77. SeraCare Life Sciences Inc. Business Overview
Table 78. SeraCare Life Sciences Inc. Fusion Transcript Assays Product
Table 79. SeraCare Life Sciences Inc. Revenue in Fusion Transcript Assays Business (2018-2023) & (US$ Million)
Table 80. SeraCare Life Sciences Inc. Recent Development
Table 81. QIAGEN Company Detail
Table 82. QIAGEN Business Overview
Table 83. QIAGEN Fusion Transcript Assays Product
Table 84. QIAGEN Revenue in Fusion Transcript Assays Business (2018-2023) & (US$ Million)
Table 85. QIAGEN Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fusion Transcript Assays Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Fusion Transcript Assays Market Share by Type: 2022 VS 2029
Figure 3. Fusion Transcript Kits Features
Figure 4. PCR Devices Features
Figure 5. Global Fusion Transcript Assays Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Fusion Transcript Assays Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Cancer Research Center Case Studies
Figure 9. Diagnostic Laboratory Case Studies
Figure 10. Others Case Studies
Figure 11. Fusion Transcript Assays Report Years Considered
Figure 12. Global Fusion Transcript Assays Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Fusion Transcript Assays Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Fusion Transcript Assays Market Share by Region: 2022 VS 2029
Figure 15. Global Fusion Transcript Assays Market Share by Players in 2022
Figure 16. Global Top Fusion Transcript Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fusion Transcript Assays as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Fusion Transcript Assays Revenue in 2022
Figure 18. North America Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Fusion Transcript Assays Market Share by Country (2018-2029)
Figure 20. United States Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Fusion Transcript Assays Market Share by Country (2018-2029)
Figure 24. Germany Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Fusion Transcript Assays Market Share by Region (2018-2029)
Figure 32. China Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Fusion Transcript Assays Market Share by Country (2018-2029)
Figure 40. Mexico Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Fusion Transcript Assays Market Share by Country (2018-2029)
Figure 44. Turkey Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Fusion Transcript Assays Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Fusion Transcript Assays Business (2018-2023)
Figure 47. Illumina, Inc. Revenue Growth Rate in Fusion Transcript Assays Business (2018-2023)
Figure 48. Merck Millipore Revenue Growth Rate in Fusion Transcript Assays Business (2018-2023)
Figure 49. Hologic Inc. Revenue Growth Rate in Fusion Transcript Assays Business (2018-2023)
Figure 50. Hologic Inc Bio-Rad Laboratories Inc. Revenue Growth Rate in Fusion Transcript Assays Business (2018-2023)
Figure 51. Caris Life Sciences Revenue Growth Rate in Fusion Transcript Assays Business (2018-2023)
Figure 52. SeraCare Life Sciences Inc. Revenue Growth Rate in Fusion Transcript Assays Business (2018-2023)
Figure 53. QIAGEN Revenue Growth Rate in Fusion Transcript Assays Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR23MA7906 )"フュージョントランススクリプトアッセイの世界市場2023年:フュージョントランススクリプトキット、PCR装置" (英文:Global Fusion Transcript Assays Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。